
doi: 10.1038/504s13a
pmid: 24352359
Genetically altered immune cells are helping to push life-threatening cancers into remission and generating a buzz.
Clinical Trials as Topic, T-Lymphocytes, Receptors, Antigen, T-Cell, Cell Separation, Adoptive Transfer, Lymphocytes, Tumor-Infiltrating, Histocompatibility Antigens, Neoplasms, Humans, Immunotherapy, Melanoma
Clinical Trials as Topic, T-Lymphocytes, Receptors, Antigen, T-Cell, Cell Separation, Adoptive Transfer, Lymphocytes, Tumor-Infiltrating, Histocompatibility Antigens, Neoplasms, Humans, Immunotherapy, Melanoma
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 46 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
